

tNGS can recover near-complete B pertussis genomes directly from clinical specimens, enabling identification of macrolide resistance mutations and high-resolution phylogenetic analysis. These findings show that tNGS complements PCR-based surveillance by providing genome-wide assessment of resistance, virulence, and genomic diversity in a single workflow.
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet
Microbe / Infectious Research
|11th Mar, 2026
|The Lancet